BiolineRX licenses Clal Biotech unit leukemia drug Globes Pre-clinical studies show that BL-8040 is efficient, both alone and in combination with the anti-cancer drug Rituximab, in reducing bone marrow metastasis of lymphoma cells and stimulating lymphoma cell death. BiolineRX CEO Dr. Kinneret Savitsky said, ... BioLineRx Nabs Phase II-Ready AML Candidate |
